New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

They’re taking the plunge. A small number of Canadian cancer patients are testing a pill that contains healthy bacteria from ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously ...

To achieve this, the researchers are utilizing fecal microbiome transfer, commonly referred to as "fecal transplant," following dietary therapy. For the fecal mibrobiome transfer, healthy people ...

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

To achieve this, the researchers are utilizing fecal microbiome transfer, commonly referred to as fecal transplant, following dietary therapy. For the fecal microbiome transfer, healthy people who ...

Scientists develop a synthetic microbiome therapy to fight C. difficile infections offering a safer, targeted alternative ...

The process, called fecal microbiota transplantation (FMT), involves taking stool from carefully screened healthy donors, processing it in the lab, and creating tasteless, odourless capsules ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative ...

Since the FDA’s approval of the first fecal transplant pills in 2023, many experts are hopeful that adapting it and similar innovations could help treat particularly resistant cancers.